Core Viewpoint - NeurAxis, Inc. is set to release its financial results for the third quarter of 2025 on November 11, 2025, before market open, followed by a conference call to discuss the results [1] Group 1: Financial Results Announcement - The financial results for the third quarter of 2025 will be reported on November 11, 2025, for the period ending September 30, 2025 [1] - A conference call is scheduled for the same day at 9:00 a.m. Eastern Time to review the financial results [1] Group 2: Conference Call Details - Interested parties can access the conference call via a live webcast available on the Company's Investor Relations website [2] - Participants can submit questions through the webcast portal or via email [2] Group 3: Company Overview - NeurAxis, Inc. focuses on neuromodulation therapies for chronic and debilitating conditions in both children and adults [4] - The Company is advancing its proprietary IB-Stim™ therapy, which is FDA cleared for treating functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents aged 8-21 [4] - Additional clinical trials for PENFS technology are ongoing for various pediatric and adult conditions with significant unmet healthcare needs [4]
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025